The Mechanism of Oxidative Stress in Pulmonary Fibrosis and Research Progress
Antioxidants · 22.01.2026 · 15 (1) · 142
DOI: 10.3390/antiox15010142 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 22.01.2026. Verfasst von Duo Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the State Key Program of National Natural Science of China, grants from the National Natural Science Foundation of China, he Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Pulmonary fibrosis (PF) is a group of chronic progressive lung diseases characterized by irreversible remodeling of lung tissue structure, abnormal proliferation of fibroblasts, and excessive deposition of extracellular matrix (ECM), among which idiopathic pulmonary fibrosis (IPF) is the most typical subtype. Currently, the only two clinically approved therapeutic drugs (nintedanib and pirfenidone) can only partially slow disease progression without reversing fibrotic lesions, and are associated with varying degrees of adverse effects. Oxidative stress, defined as a pathological imbalance between systemic oxidant and antioxidant systems, has been substantiated by extensive research as a pivotal mechanism driving the pathogenesis and progression of pulmonary fibrosis. This review summarizes the regulatory mechanisms of oxidative stress in pulmonary fibrosis, with a focus on its critical role in inducing and promoting fibrosis through relevant target cells and signaling pathways. We also specifically highlight the latest progress and challenges in therapeutic strategies targeting oxidative stress, and discuss next-generation therapies, including the modulation of endogenous antioxidant pathways, supplementation of exogenous antioxidants, as well as nanomaterials, exosomes, and combination therapies. We hope this review will deepen the understanding of oxidative stress and pulmonary fibrosis, and provide new directions for improving the clinical efficacy of oxidative stress-targeted therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
ORCID-Profile: Xianglin Yuan, Yongbiao Huang
Förderung
- the State Key Program of National Natural Science of China
- grants from the National Natural Science Foundation of China
- he Noncommunicable Chronic Diseases-National Science and Technology Major Project
- the National Natural Science Foundation of China
- the Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Xu, D., Wang, Q., Lyu, M., Huang, C., Yuan, X., Chen, X., & Huang, Y. (2026). The Mechanism of Oxidative Stress in Pulmonary Fibrosis and Research Progress. Antioxidants, 15(1), 142. https://doi.org/10.3390/antiox15010142
Vancouver
Xu D, Wang Q, Lyu M, Huang C, Yuan X, Chen X, et al. The Mechanism of Oxidative Stress in Pulmonary Fibrosis and Research Progress. Antioxidants. 2026;15(1):142. doi:10.3390/antiox15010142
BibTeX
@article{Xu2026,
author = {Xu, Duo and Wang, Qian and Lyu, Meng and Huang, Chunyu and Yuan, Xianglin and Chen, Xinyi and Huang, Yongbiao},
title = {The Mechanism of Oxidative Stress in Pulmonary Fibrosis and Research Progress},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {1},
pages = {142},
doi = {10.3390/antiox15010142}
}
EUVIMED